This post was just published on ZYX Short Change Alert.
FRX is a pharmaceutical company that is running up in the pre-market as it buys another company. The irony is that FRX stock has been levitating in part because this company was supposed to be a buy out candidate. The acquisition this company has made reduces the chances of a buyout.
Consider starting a 10% tranche right here in the pre-market around $68.15 – $69. Accumulate up to 40% all the way to $75. Stop zone $77 to $81. Target zone $50 to $52.
